Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies
US7988975B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2005 |
| Grant date | Aug 2, 2011 |
| Priority date | — |
| Expiry date | Aug 12, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention involves a synthetic peptide derived from HIV-1 virus gp41 having sequencewhere X615 is F or G, a method of preparing the synthetic peptide, a composition and a kit containing the synthetic peptide, and use of the synthetic peptide in immunoassays for the detection of infections caused by HIV-1 viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.